688399 硕世生物
交易中 05-27 10:12:14
资讯
新帖
简况
硕世生物(688399.SH)取得医疗器械注册证
智通财经 · 05-06
硕世生物(688399.SH)取得医疗器械注册证
股市必读：硕世生物(688399)股东户数0.85万户，较上期增加3.3%
证券之星 · 05-06
股市必读：硕世生物(688399)股东户数0.85万户，较上期增加3.3%
每周股票复盘：硕世生物（688399）股东户数增3.3%
证券之星 · 05-02
每周股票复盘：硕世生物（688399）股东户数增3.3%
图解硕世生物一季报：第一季度单季净利润同比增长64.77%
证券之星 · 04-29
图解硕世生物一季报：第一季度单季净利润同比增长64.77%
每周股票复盘：硕世生物（688399）2025年净亏损4107.85万元
证券之星 · 04-26
每周股票复盘：硕世生物（688399）2025年净亏损4107.85万元
图解硕世生物年报：第四季度单季净利润同比下降51.91%
证券之星 · 04-23
图解硕世生物年报：第四季度单季净利润同比下降51.91%
每周股票复盘：硕世生物（688399）股东户数增3.3%至8459户
证券之星 · 04-19
每周股票复盘：硕世生物（688399）股东户数增3.3%至8459户
股市必读：硕世生物（688399）今年截至4月3日累计跌幅已超20%
证券之星 · 04-07
股市必读：硕世生物（688399）今年截至4月3日累计跌幅已超20%
每周股票复盘：硕世生物（688399）股东户数增2.31%至8189户
证券之星 · 04-05
每周股票复盘：硕世生物（688399）股东户数增2.31%至8189户
每周股票复盘：硕世生物（688399）股东户数减少239户至8004户
证券之星 · 03-29
每周股票复盘：硕世生物（688399）股东户数减少239户至8004户
硕世生物净利连亏3年 2019年IPO募7亿招商证券保荐
中金财经 · 03-11
硕世生物净利连亏3年 2019年IPO募7亿招商证券保荐
硕世生物(688399.SH)2025年度归母净亏损3971.03万元
智通财经 · 02-27
硕世生物(688399.SH)2025年度归母净亏损3971.03万元
每周股票复盘：硕世生物（688399）股东户数增17.41%，户均持股下降
证券之星 · 01-18
每周股票复盘：硕世生物（688399）股东户数增17.41%，户均持股下降
硕世生物(688399)1月9日股东户数0.86万户，较上期增加17.41%
证券之星 · 01-12
硕世生物(688399)1月9日股东户数0.86万户，较上期增加17.41%
每周股票复盘：硕世生物（688399）拟拓展光伏电力业务
证券之星 · 2025-12-28
每周股票复盘：硕世生物（688399）拟拓展光伏电力业务
股市必读：12月24日硕世生物发生1笔大宗交易 成交金额373.38万元
证券之星 · 2025-12-25
股市必读：12月24日硕世生物发生1笔大宗交易 成交金额373.38万元
硕世生物（688399）披露拟增加发电业务经营范围，12月24日股价下跌0.43%
证券之星 · 2025-12-24
硕世生物（688399）披露拟增加发电业务经营范围，12月24日股价下跌0.43%
12月23日硕世生物现399.8万元大宗交易
证券之星 · 2025-12-23
12月23日硕世生物现399.8万元大宗交易
硕世生物最新公告：公司猴痘病毒核酸检测试剂盒被列入WHO应急使用清单
证券之星 · 2025-12-07
硕世生物最新公告：公司猴痘病毒核酸检测试剂盒被列入WHO应急使用清单
硕世生物（688399）披露实际控制人续签一致行动协议，12月05日股价下跌0.77%
证券之星 · 2025-12-05
硕世生物（688399）披露实际控制人续签一致行动协议，12月05日股价下跌0.77%
加载更多
公司概况
公司名称：
江苏硕世生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2019-12-05
主营业务：
江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是诊断试剂、诊断仪器、检测服务。
发行价格：
46.78
{"stockData":{"symbol":"688399","market":"SH","secType":"STK","nameCN":"硕世生物","latestPrice":56.7,"timestamp":1779847934000,"preClose":55.75,"halted":0,"volume":665992,"delay":0,"changeRate":0.017,"floatShares":83871700,"shares":83871700,"eps":-0.3908,"marketStatus":"交易中","change":0.95,"latestTime":"05-27 10:12:14","open":56.86,"high":57.42,"low":55.2,"amount":37530900,"amplitude":0.0398,"askPrice":56.74,"askSize":6,"bidPrice":56.73,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-0.3908,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1779852600000},"marketStatusCode":2,"adr":0,"adjPreClose":55.75,"symbolType":"stock_kcb","openAndCloseTimeList":[[1779845400000,1779852600000],[1779858000000,1779865200000]],"highLimit":61.33,"lowLimit":50.18,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":83871721,"isCdr":false,"pbRate":1.59,"roa":"--","roe":"0.72%","epsLYR":-0.49,"committee":-0.591398,"marketValue":4756000000,"turnoverRate":0.0079,"status":0,"floatMarketCap":4756000000},"requestUrl":"/m/hq/s/688399","defaultTab":"news","newsList":[{"id":"2633185865","title":"硕世生物(688399.SH)取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2633185865","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633185865?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:48","pubTimestamp":1778060883,"startTime":"0","endTime":"0","summary":"智通财经APP讯，硕世生物(688399.SH)发布公告，公司近日收到国家药品监督管理局签发的医疗器械注册证(体外诊断试剂)，产品名称：甲型H1N1(2009)和季节性H3亚型流感病毒核酸检测试剂盒(荧光PCR法)，该试剂盒用于体外定性检测人咽拭子样本中甲型H1N1(2009)和季节性H3亚型流感病毒核酸。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438595.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK0239","09996","BK1574","09997","BK1222","688399","BK1583","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633992220","title":"股市必读：硕世生物(688399)股东户数0.85万户，较上期增加3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633992220","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633992220?lang=zh_cn&edition=full","pubTime":"2026-05-06 05:05","pubTimestamp":1778015116,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，硕世生物报收于61.75元，上涨1.73%，换手率1.66%，成交量1.4万手，成交额8667.58万元。当日关注点来自交易信息汇总：4月30日主力资金净流出532.11万元，占总成交额6.14%。股本股东变化股东户数变动近日硕世生物披露，截至2026年4月10日公司股东户数为8459.0户，较3月31日增加270.0户，增幅为3.3%。户均持股数量由上期的1.02万股减少至9915.0股，户均持股市值为51.43万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632446628","title":"每周股票复盘：硕世生物（688399）股东户数增3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632446628","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632446628?lang=zh_cn&edition=full","pubTime":"2026-05-02 05:31","pubTimestamp":1777671074,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，硕世生物报收于61.75元，较上周的60.97元上涨1.28%。本周，硕世生物4月28日盘中最高价报63.63元。硕世生物当前最新总市值51.79亿元，在医疗器械板块市值排名73/129，在两市A股市值排名3398/5200。股本股东变化股东户数变动截至2026年4月10日，硕世生物股东户数为8459.0户，较3月31日增加270.0户，增幅3.3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631951684","title":"图解硕世生物一季报：第一季度单季净利润同比增长64.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631951684","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631951684?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:53","pubTimestamp":1777463622,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物2026年一季报显示，一季度公司主营收入7858.4万元，同比下降14.22%；归母净利润2112.22万元，同比上升64.77%；扣非净利润-401.22万元，同比上升28.1%；负债率19.56%，投资收益187.01万元，财务费用240.12万元，毛利率58.72%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900060958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630080283","title":"每周股票复盘：硕世生物（688399）2025年净亏损4107.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630080283","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630080283?lang=zh_cn&edition=full","pubTime":"2026-04-26 04:34","pubTimestamp":1777149251,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，硕世生物报收于60.97元，较上周的57.0元上涨6.96%。本周，硕世生物4月24日盘中最高价报63.38元。硕世生物当前最新总市值51.14亿元，在医疗器械板块市值排名72/129，在两市A股市值排名3401/5200。来自业绩披露要点：硕世生物2025年归母净利润为-4107.85万元，同比下降1952.18%。来自公司公告汇总：硕世生物拟每10股转增4.8股，不派发现金红利。股本股东变化股东户数变动截至2026年4月10日，硕世生物股东户数为8459.0户，较3月31日增加270.0户，增幅3.3%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629029180","title":"图解硕世生物年报：第四季度单季净利润同比下降51.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629029180","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629029180?lang=zh_cn&edition=full","pubTime":"2026-04-23 01:14","pubTimestamp":1776878079,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物2025年年报显示，当年度公司主营收入3.39亿元，同比下降3.02%；归母净利润-4107.85万元，同比下降1952.18%；扣非净利润-1.03亿元，同比下降42.75%；其中2025年第四季度，公司单季度主营收入8153.96万元，同比上升0.02%；单季度归母净利润-4423.01万元，同比下降51.91%；单季度扣非净利润-6115.57万元，同比下降10.45%；负债率17.6%，投资收益697.95万元，财务费用227.43万元，毛利率63.16%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300002434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628756191","title":"每周股票复盘：硕世生物（688399）股东户数增3.3%至8459户","url":"https://stock-news.laohu8.com/highlight/detail?id=2628756191","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628756191?lang=zh_cn&edition=full","pubTime":"2026-04-19 01:43","pubTimestamp":1776534188,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，硕世生物报收于57.0元，较上周的51.87元上涨9.89%。本周，硕世生物4月17日盘中最高价报57.61元。4月13日盘中最低价报49.2元。硕世生物当前最新总市值47.81亿元，在医疗器械板块市值排名80/129，在两市A股市值排名3584/5198。本周关注点股本股东变化：股东户数增3.3%至8459户股本股东变化股东户数变动截至2026年4月10日，公司股东户数为8459.0户，较3月31日增加270.0户，增幅3.3%；户均持股由1.02万股降至9915.0股，户均持股市值为51.43万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625606677","title":"股市必读：硕世生物（688399）今年截至4月3日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625606677","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625606677?lang=zh_cn&edition=full","pubTime":"2026-04-07 03:06","pubTimestamp":1775502374,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，硕世生物报收于51.12元，下跌2.94%，换手率0.87%，成交量7275.0手，成交额3727.03万元。交易信息汇总股价提醒4月3日硕世生物收盘报51.12元，跌2.94%，当日成交72.75万元。该股已连续2日下跌，当年累计跌幅21.18%。前10个交易日中，主力资金累计净流出5549.29万元，股价累计下跌10.79%；融资余额累计减少2117.81万元，融券余量累计减少1700股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700002091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625361996","title":"每周股票复盘：硕世生物（688399）股东户数增2.31%至8189户","url":"https://stock-news.laohu8.com/highlight/detail?id=2625361996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625361996?lang=zh_cn&edition=full","pubTime":"2026-04-05 03:00","pubTimestamp":1775329236,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，硕世生物报收于51.12元，较上周的55.6元下跌8.06%。本周，硕世生物3月30日盘中最高价报55.86元。本周关注点股本股东变化：股东户数较3月20日增加2.31%，达8189.0户股本股东变化：户均持股数量由1.05万股降至1.02万股股本股东变化：户均持股市值为53.77万元股本股东变化股东户数变动截至2026年3月31日，硕世生物股东户数为8189.0户，较3月20日增加185.0户，增幅2.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623133882","title":"每周股票复盘：硕世生物（688399）股东户数减少239户至8004户","url":"https://stock-news.laohu8.com/highlight/detail?id=2623133882","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623133882?lang=zh_cn&edition=full","pubTime":"2026-03-29 03:01","pubTimestamp":1774724473,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，硕世生物报收于55.6元，较上周的58.69元下跌5.26%。本周，硕世生物3月23日盘中最高价报58.6元。3月27日盘中最低价报53.88元。硕世生物当前最新总市值46.63亿元，在医疗器械板块市值排名78/129，在两市A股市值排名3542/5191。户均持股数量由上期的1.02万股上升至1.05万股，户均持股市值为61.5万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618916596","title":"硕世生物净利连亏3年 2019年IPO募7亿招商证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2618916596","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618916596?lang=zh_cn&edition=full","pubTime":"2026-03-11 14:57","pubTimestamp":1773212223,"startTime":"0","endTime":"0","summary":"中国经济网北京3月11日讯 硕世生物 日前发布2025年度业绩快报公告，公司实现营业收入34,038.04万元，同比下降2.64%；实现归属于母公司所有者的净利润-3,971.03万元，同比亏损扩大3,770.86万元；实现归属于母公司所有者的扣除非经常性损益的净利润-10,383.16万元，同比亏损扩大3,199.45万元。 硕世生物首次公开发行股票的发行费用总额为7,286.12万元，其中，保荐及承销费用为5,493.46万元。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/11/20260311842746.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/11/20260311842746.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260311/32060006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0012","BK0028","06099","BK0010","BK1147","688399","BK0239","BK1564","BK0276","BK0183","BK0188","600999"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614385074","title":"硕世生物(688399.SH)2025年度归母净亏损3971.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614385074","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614385074?lang=zh_cn&edition=full","pubTime":"2026-02-27 23:40","pubTimestamp":1772206855,"startTime":"0","endTime":"0","summary":"智通财经APP讯，硕世生物(688399.SH)披露2025年度业绩快报，公司实现营业总收入3.4亿元，同比下降2.64%;实现归属于母公司所有者的净亏损3971.03万元;实现归属于母公司所有者的扣除非经常性损益的净亏损1.04亿元。报告期内，公司主营业务稳定发展，但受行业竞争加剧及医疗集采持续推进等影响，报告期内自产检测试剂产品增值税税率调整为13%，上述因素叠加导致分子诊断试剂的收入有所下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604763925","title":"每周股票复盘：硕世生物（688399）股东户数增17.41%，户均持股下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2604763925","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604763925?lang=zh_cn&edition=full","pubTime":"2026-01-18 04:30","pubTimestamp":1768681825,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，硕世生物报收于77.7元，较上周的79.98元下跌2.85%。本周，硕世生物1月13日盘中最高价报83.38元，股价触及近一年最高点。本周关注点股本股东变化：截至2026年1月9日股东户数为8573.0户，较前期增加1271.0户，增幅17.41%股本股东变化：户均持股数量由上期1.15万股减少至9783.0股股本股东变化：户均持股市值为78.25万元股本股东变化股东户数变动截至2026年1月9日，硕世生物股东户数为8573.0户，较12月31日增加1271.0户，增幅17.41%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602184365","title":"硕世生物(688399)1月9日股东户数0.86万户，较上期增加17.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602184365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602184365?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:37","pubTimestamp":1768210673,"startTime":"0","endTime":"0","summary":"证券之星消息，近日硕世生物披露，截至2026年1月9日公司股东户数为8573.0户，较12月31日增加1271.0户，增幅为17.41%。在医疗器械行业个股中，硕世生物股东户数低于行业平均水平，截至1月9日，医疗器械行业平均股东户数为2.19万户。从股价来看，2025年12月31日至2026年1月9日，硕世生物区间涨幅为16.76%，在此期间股东户数增加1271.0户，增幅为17.41%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200024342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594247965","title":"每周股票复盘：硕世生物（688399）拟拓展光伏电力业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2594247965","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594247965?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:12","pubTimestamp":1766869933,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，硕世生物报收于70.91元，较上周的67.24元上涨5.46%。本周，硕世生物12月25日盘中最高价报73.49元。硕世生物当前最新总市值59.47亿元，在医疗器械板块市值排名59/127，在两市A股市值排名2951/5178。本周关注点公司公告汇总：硕世生物拟增加发电、输电、供（配）电业务，涉及园区光伏发电自用及售电。交易信息汇总12月24日硕世生物发生1笔大宗交易，成交金额373.38万元。12月23日硕世生物发生一笔399.8万元大宗交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594401471","title":"股市必读：12月24日硕世生物发生1笔大宗交易 成交金额373.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594401471","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594401471?lang=zh_cn&edition=full","pubTime":"2025-12-25 03:51","pubTimestamp":1766605872,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘，硕世生物报收于67.61元，下跌0.43%，换手率1.48%，成交量1.24万手，成交额8361.88万元。当日关注点来自交易信息汇总：12月24日主力与游资资金均呈净流入，合计达578.67万元，而散户资金净流出同等规模。来自公司公告汇总：硕世生物拟于2026年第一次临时股东会审议新增电力相关经营范围，涉及园区光伏发电自用及售电业务。大宗交易12月24日硕世生物发生1笔大宗交易，成交金额373.38万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500001676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593408589","title":"硕世生物（688399）披露拟增加发电业务经营范围，12月24日股价下跌0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593408589","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593408589?lang=zh_cn&edition=full","pubTime":"2025-12-24 22:45","pubTimestamp":1766587518,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘，硕世生物报收于67.61元，较前一交易日下跌0.43%，最新总市值为56.71亿元。该股当日开盘68.6元，最高68.6元，最低66.77元，成交额达8361.88万元，换手率为1.48%。根据公司近日发布的公告，江苏硕世生物科技股份有限公司拟增加公司经营范围，新增发电业务、输电业务、供（配）电业务，主要为园区内光伏发电设备所发电量自用及多余电量销售。该事项已提交2026年第一次临时股东会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400041415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593496197","title":"12月23日硕世生物现399.8万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2593496197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593496197?lang=zh_cn&edition=full","pubTime":"2025-12-23 17:57","pubTimestamp":1766483860,"startTime":"0","endTime":"0","summary":"证券之星消息，12月23日硕世生物发生大宗交易，交易数据如下：大宗交易成交价格63.46元，相对当日收盘价折价6.54%，成交6.3万股，成交金额399.8万元，买方营业部为平安证券股份有限公司山东分公司，卖方营业部为华西证券股份有限公司济南分公司。近三个月该股共发生2笔大宗交易，合计成交1010.0手，折价成交2笔。截至2025年12月23日收盘，硕世生物报收于67.9元，上涨1.65%，换手率1.94%，成交量1.63万手，成交额1.11亿元。该股最近90天内无机构评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300029191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589876710","title":"硕世生物最新公告：公司猴痘病毒核酸检测试剂盒被列入WHO应急使用清单","url":"https://stock-news.laohu8.com/highlight/detail?id=2589876710","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589876710?lang=zh_cn&edition=full","pubTime":"2025-12-07 15:40","pubTimestamp":1765093233,"startTime":"0","endTime":"0","summary":"硕世生物(688399.SH)公告称，公司产品猴痘病毒核酸检测试剂盒（荧光PCR法）于近日被列入世界卫生组织（WHO）应急使用清单。该产品批准日期为2025年12月3日，采购期限为1年。公司表示，被列入WHO EUL可为WHO成员国和各意向采购方提供采购依据，对公司产品在相关海外市场的推广和销售起到推动作用。但实际销售情况受海外市场政策环境、检测需求、同类产品竞争等因素影响，产品销售规模存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120700002594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589813852","title":"硕世生物（688399）披露实际控制人续签一致行动协议，12月05日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589813852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589813852?lang=zh_cn&edition=full","pubTime":"2025-12-05 22:23","pubTimestamp":1764944605,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘，硕世生物报收于67.98元，较前一交易日下跌0.77%，最新总市值为57.02亿元。该股当日开盘68.94元，最高68.94元，最低67.1元，成交额达5547.08万元，换手率为0.98%。公司近日发布公告称，实际控制人房永生、梁锡林、王国强于2025年12月5日续签《一致行动协议》，协议自签署日起生效，有效期十二个月。本次续签旨在保持公司经营的连续性与稳定性，确保决策一致性。续签后公司实际控制权未发生变化，不存在损害中小投资者利益的情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500040463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779847939185,"stockEarnings":[{"period":"1week","weight":-0.0745},{"period":"1month","weight":-0.0856},{"period":"3month","weight":-0.12},{"period":"6month","weight":-0.2007},{"period":"1year","weight":0.2671},{"period":"ytd","weight":-0.1861}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":0.016},{"period":"3month","weight":-0.0004},{"period":"6month","weight":0.0697},{"period":"1year","weight":0.2386},{"period":"ytd","weight":0.0445}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏硕世生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8733人(较上一季度增加2.92%)","perCapita":"9603股","listingDate":"2019-12-05","address":"江苏省泰州市海陵区药城大道837号","registeredCapital":"8387万元","survey":" 江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是诊断试剂、诊断仪器、检测服务。","listedPrice":46.78},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"硕世生物,688399,硕世生物股票,硕世生物股票老虎,硕世生物股票老虎国际,硕世生物行情,硕世生物股票行情,硕世生物股价,硕世生物股市,硕世生物股票价格,硕世生物股票交易,硕世生物股票购买,硕世生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}